Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Milestone Pharmaceuticals Inc. before investing.

In this article, we go over a few key elements for understanding Milestone Pharmaceuticals Inc.’s stock price such as:

• Milestone Pharmaceuticals Inc.’s current stock price and volume
• Why Milestone Pharmaceuticals Inc.’s stock price changed recently
• Upgrades and downgrades for MIST from analysts
• MIST’s stock price momentum as measured by its relative strength

About Milestone Pharmaceuticals Inc. (MIST)

Before we jump into Milestone Pharmaceuticals Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.

Want to learn more about Milestone Pharmaceuticals Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Milestone Pharmaceuticals Inc..

Milestone Pharmaceuticals Inc.’s Stock Price as of Market Close

As of May 13, 2026, 3:02 PM, CST, Milestone Pharmaceuticals Inc.’s stock price was $1.713.

Milestone Pharmaceuticals Inc. is down 9.83% from its previous closing price of $1.900.

During the last market session, Milestone Pharmaceuticals Inc.’s stock traded between $1.570 and $1.890. Currently, there are approximately 106.04 million shares outstanding for Milestone Pharmaceuticals Inc..

Milestone Pharmaceuticals Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Milestone Pharmaceuticals Inc. Stock Price History

Milestone Pharmaceuticals Inc.’s (MIST) price is currently down 4.82% so far this month.

During the month of May, Milestone Pharmaceuticals Inc.’s stock price has reached a high of $2.020 and a low of $1.570.

Over the last year, Milestone Pharmaceuticals Inc. has hit prices as high as $3.060 and as low as $1.000. Year to date, Milestone Pharmaceuticals Inc.’s stock is down 15.18%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Milestone Pharmaceuticals Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 12, 2026, there were 0 analysts who downgraded Milestone Pharmaceuticals Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Milestone Pharmaceuticals Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Milestone Pharmaceuticals Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Milestone Pharmaceuticals Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Milestone Pharmaceuticals Inc. (MIST) by visiting AAII Stock Evaluator.

Relative Price Strength of Milestone Pharmaceuticals Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 12, 2026, Milestone Pharmaceuticals Inc. has a weighted four-quarter relative price strength of 4.63%, which translates to a Momentum Score of 72 and is considered to be Strong.

Want to learn more about how Milestone Pharmaceuticals Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Milestone Pharmaceuticals Inc. Stock Price: Bottom Line

As of May 13, 2026, Milestone Pharmaceuticals Inc.’s stock price is $1.713, which is down 9.83% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Milestone Pharmaceuticals Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.